These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34497119)

  • 1. lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells.
    Parker KA; Gooding AJ; Valadkhan S; Schiemann WP
    Mol Cancer Res; 2021 Dec; 19(12):2068-2080. PubMed ID: 34497119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.
    Gooding AJ; Zhang B; Jahanbani FK; Gilmore HL; Chang JC; Valadkhan S; Schiemann WP
    Sci Rep; 2017 Oct; 7(1):12698. PubMed ID: 28983112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
    Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
    Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin α6 (CD49f), The Microenvironment and Cancer Stem Cells.
    Bigoni-Ordóñez GD; Czarnowski D; Parsons T; Madlambayan GJ; Villa-Diaz LG
    Curr Stem Cell Res Ther; 2019; 14(5):428-436. PubMed ID: 30280675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.
    Gooding AJ; Zhang B; Gunawardane L; Beard A; Valadkhan S; Schiemann WP
    Oncogene; 2019 Mar; 38(12):2020-2041. PubMed ID: 30467380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population.
    Gómez-Miragaya J; Palafox M; Paré L; Yoldi G; Ferrer I; Vila S; Galván P; Pellegrini P; Pérez-Montoyo H; Igea A; Muñoz P; Esteller M; Nebreda AR; Urruticoechea A; Morilla I; Pernas S; Climent F; Soler-Monso MT; Petit A; Serra V; Prat A; González-Suárez E
    Stem Cell Reports; 2017 May; 8(5):1392-1407. PubMed ID: 28457887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
    Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
    Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling.
    Luo F; Zhang M; Sun B; Xu C; Yang Y; Zhang Y; Li S; Chen G; Chen C; Li Y; Feng H
    Mol Cancer; 2024 Mar; 23(1):60. PubMed ID: 38520019
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Jana S; Mondal M; Mahale S; Gupta B; Prasasvi KR; Kandasami L; Jha N; Chowdhury A; Santosh V; Kanduri C; Somasundaram K
    Elife; 2024 Sep; 12():. PubMed ID: 39302097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells.
    Kai K; Iwamoto T; Kobayashi T; Arima Y; Takamoto Y; Ohnishi N; Bartholomeusz C; Horii R; Akiyama F; Hortobagyi GN; Pusztai L; Saya H; Ueno NT
    Oncogene; 2014 Jan; 33(4):440-8. PubMed ID: 23376849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Invasive Basal Phenotype in Triple-Negative Breast Cancers by Long Noncoding RNA BORG.
    Niazi F; Parker KA; Mason SJ; Singh S; Schiemann WP; Valadkhan S
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer.
    Shen Y; Cao J; Liang Z; Lin Q; Wang J; Yang X; Zhang R; Zong J; Du X; Peng Y; Zhang J; Shi J
    Cell Commun Signal; 2019 May; 17(1):50. PubMed ID: 31122254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.
    Xu Z; Liu C; Zhao Q; Lü J; Ding X; Luo A; He J; Wang G; Li Y; Cai Z; Wang Z; Liu J; Liu S; Li W; Yu Z
    Pharmacol Res; 2020 Feb; 152():104628. PubMed ID: 31904506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers.
    Tu Z; Schmöllerl J; Cuiffo BG; Karnoub AE
    Stem Cells; 2019 Oct; 37(10):1281-1292. PubMed ID: 31283068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
    Hoogland AM; Verhoef EI; Roobol MJ; Schröder FH; Wildhagen MF; van der Kwast TH; Jenster G; van Leenders GJ
    Prostate; 2014 May; 74(5):488-96. PubMed ID: 24375374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination.
    Tsang SV; Rainusso N; Liu M; Nomura M; Patel TD; Nakahata K; Kim HR; Huang S; Rajapakshe K; Coarfa C; Man TK; Rao PH; Yustein JT
    Oncogene; 2022 Dec; 41(50):5373-5384. PubMed ID: 36348010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA activated by transforming growth factor-β promotes proliferation and invasion of cervical cancer cells by regulating the miR-144/ITGA6 axis.
    Zhu Y; Wu Y; Yang L; Dou X; Jiang J; Wang L
    Exp Physiol; 2019 Jun; 104(6):837-844. PubMed ID: 30908730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth.
    Li M; Pan M; You C; Zhao F; Wu D; Guo M; Xu H; Shi F; Zheng D; Dou J
    Breast Cancer Res; 2020 Mar; 22(1):26. PubMed ID: 32143670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency.
    Atkinson RL; Yang WT; Rosen DG; Landis MD; Wong H; Lewis MT; Creighton CJ; Sexton KR; Hilsenbeck SG; Sahin AA; Brewster AM; Woodward WA; Chang JC
    Breast Cancer Res; 2013; 15(5):R77. PubMed ID: 24008095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.